Procedural Decision-Making

Transfusion Procedure Logic

Procedural questions test performing laboratory techniques and following protocols. The richest source of procedural items is the blood bank, where every step is rule-driven. The exam is one-best-answer multiple choice, so first identify the action requested, then choose the option that follows protocol exactly.

ABO selection follows fixed compatibility. For red blood cell transfusion, the donor cells must lack antigens the recipient has antibodies against; for plasma, the reverse applies. Group O is the universal red cell donor; group AB is the universal plasma donor. Memorize the emergency-release defaults: when the type is unknown, give O-negative red cells (especially to females of childbearing potential) and AB plasma.

A positive antibody screen triggers a procedural cascade: run an antibody identification panel, determine specificity, then provide antigen-negative, crossmatch-compatible units. If anti-K is identified, you select K-negative units and confirm with an antiglobulin (AHG) crossmatch. The trap is to issue least-incompatible units without first completing identification, which the protocol does not permit outside true emergencies with physician sign-off.

The Rh(D) decision adds a second procedural layer. D-negative recipients should receive D-negative red cells whenever possible to avoid forming anti-D, and this is enforced most strictly for females of childbearing potential because anti-D causes hemolytic disease of the fetus and newborn. After a D-positive exposure in a D-negative patient, the procedural follow-up is a fetomaternal hemorrhage (rosette or Kleihauer-Betke) screen and appropriate Rh immune globulin (RhIG) dosing. A weak D (formerly Du) result on a patient is investigated before labeling the type, because some weak-D phenotypes can still form anti-D.

The crossmatch phase also signals the procedural answer: an incompatibility appearing only at the immediate-spin phase suggests ABO or a cold antibody, whereas incompatibility at the antiglobulin (AHG) phase suggests a clinically significant warm IgG alloantibody requiring full identification.

Resolving Discrepancies And Microbiology Steps

An ABO discrepancy exists when forward typing (patient cells + reagent antisera) and reverse typing (patient serum + reagent cells) disagree. The procedural answer resolves the cause before reporting a type:

• Missing reverse reaction in a newborn or hypogammaglobulinemic patient: weak or absent isoagglutinins are expected; investigate clinically.
• Extra reverse reaction: suspect a cold autoantibody, alloantibody, or rouleaux; warm the sample or perform saline replacement.
• Mixed-field forward reaction: consider recent transfusion of a different type, a subgroup, or a transplant.
• Acquired B phenomenon: seen in group A patients with gram-negative sepsis; the procedural step is to test with monoclonal anti-B and acidified serum.

Microbiology procedures are equally protocol-bound. A urine culture growing >100,000 CFU/mL of a single uropathogen meets the threshold for significant bacteriuria and proceeds to identification and susceptibility testing; mixed flora at low counts suggests contamination and is reported as such. For a positive blood culture, the procedural sequence is Gram stain first (call the result as a critical value), then subculture to appropriate media, identify, and perform susceptibility testing.

Antimicrobial susceptibility uses defined breakpoints; methicillin resistance is confirmed with cefoxitin disk screening or detection of the mecA gene, not by reading oxacillin alone.

A worked procedural case: a crossmatch is incompatible at the AHG phase, the antibody screen is positive, and the patient was transfused two weeks ago. The procedural decision is to perform an antibody identification panel to characterize a likely delayed alloantibody, then select antigen-negative units and repeat an AHG crossmatch. Choosing to issue uncrossmatched O-negative units would be wrong because there is no life-threatening emergency described and the discrepancy must first be resolved.

When reviewing a procedural miss, ask whether the chosen option performed the correct technique for the stated situation and whether it respected the required sequence. Many distractors are real laboratory actions placed in the wrong order, such as issuing units before completing identification, or reporting a culture before reaching the colony-count threshold. The best answer is the next correct step in the protocol, not merely a plausible laboratory activity, because the exam consistently rewards correct sequence over a list of correct-sounding tasks.

Procedural items also test recognition of a transfusion reaction in progress and the required sequence. At the first sign of fever, chills, hypotension, or back pain during transfusion, the protocol is to stop the transfusion immediately, keep the IV line open with saline, and notify the physician and blood bank before anything else. Only then does the laboratory work begin: a clerical check of the unit and patient identification, a visual inspection of post-reaction plasma for hemolysis (pink or red), a repeat ABO/Rh on the post-reaction specimen, and a direct antiglobulin test (DAT).

A positive DAT with visible hemolysis points to an acute hemolytic reaction from ABO incompatibility, most often caused by a clerical or identification error rather than a missed antibody. Selecting an option that orders these steps incorrectly, or that continues the transfusion while investigating, is the wrong answer no matter how technically detailed it sounds.